Skip to content
NBlaz – Lifestyle
Author:
Cogent Biosciences, Inc.
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
March 16, 2026
←
Previous Page
1
2